Meeder Asset Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-766
| Closed | -$12K | – | 2673 |
|
|
2020
Q1 | $12K | Sell |
766
-2,429
| -76% | -$38.1K | ﹤0.01% | 1457 |
|
|
2019
Q4 | $52K | Buy |
3,195
+2,842
| +805% | +$46.3K | ﹤0.01% | 1010 |
|
|
2019
Q3 | $5K | Hold |
353
| – | – | ﹤0.01% | 1793 |
|
|
2019
Q2 | $6K | Sell |
353
-2,876
| -89% | -$48.9K | ﹤0.01% | 1641 |
|
|
2019
Q1 | $57K | Sell |
3,229
-217
| -6% | -$3.83K | ﹤0.01% | 846 |
|
|
2018
Q4 | $61K | Buy |
3,446
+3,188
| +1,236% | +$56.4K | 0.01% | 762 |
|
|
2018
Q3 | $4K | Buy |
+258
| New | +$4K | ﹤0.01% | 1380 |
|
|
2018
Q2 | – | Sell |
-53
| Closed | -$1K | – | 1736 |
|
|
2018
Q1 | $1K | Sell |
53
-496
| -90% | -$9.36K | ﹤0.01% | 1510 |
|
|
2017
Q4 | $6K | Buy |
549
+66
| +14% | +$721 | ﹤0.01% | 1290 |
|
|
2017
Q3 | $5K | Sell |
483
-62
| -11% | -$642 | ﹤0.01% | 1298 |
|
|
2017
Q2 | $5K | Sell |
545
-74
| -12% | -$679 | ﹤0.01% | 1224 |
|
|
2017
Q1 | $7K | Buy |
619
+265
| +75% | +$3K | ﹤0.01% | 977 |
|
|
2016
Q4 | $5K | Buy |
+354
| New | +$5K | ﹤0.01% | 867 |
|